Determinants of outcome of compensated hepatitis C virus-related cirrhosis

Hepatology

Volumn 27, Issue 5, 1998, Pages 1435-1440

  Serfaty, Lawrence ^a   Aumaître, Hugues ^a   Chazouillères, Olivier ^a   Bonnand, Anne Marie ^b   Rosmorduc, Olivier ^a   Poupon, Renée E ^b   Poupon, Raoul ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS C ANTIBODY; PROTHROMBIN; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; CONTROLLED STUDY; ESOPHAGUS VARICES BLEEDING; FEMALE; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; JAUNDICE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; VIRUS TYPING;

ADULT; AGED; ASCITES; FEMALE; HEPATITIS C; HUMANS; INTERFERON-ALPHA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; VARICOSE VEINS;

EID: 0031960043     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270535     Document Type: Article

References (15)

1. Feray C, Gigou M, Samuel D, Paradis V, David MF, Lemonnier C, et al. The course of hepatitis C virus infection after liver transplantation. HEPATOLOGY 1994;20:1137-1143.
2. Seef LB, Buskell-Bales Z, Wright EC, Durako SJ, Alter HJ, Iber FL, et al. Long-term mortality after transfusion-associated Non-A, Non-B hepatitis. N Engl J Med 1992;327:1906-1911.
3. Koretz RL, Abey H, Coleman E, Gitnick G. Non-A, non-B posttransfusion hepatitis: looking back in the second decade. Ann Intern Med 1993;119:110-115.
4. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. HEPATOLOGY 1991;14:969-74.
5. Hopf U, Küther D, Stemerowicz R, Stemerowicz R, Lobeck H, Lüdtke-Handjery A, et al. Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). J Hepatol 1990;10:69-76.
6. Tremolada F, Casarin C, Alberti A, Drago C, Tagger A, Ribero ML, et al. Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis. J Hepatol 1992;16:273-281.
7. Tong JM, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995;332:1463-1466.
8. Colombo M, De Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tomasini M, et al. Hepatocellular carcinoma in italian patients with cirrhosis. N Engl J Med 1991;325:675-680.
9. Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. HEPATOLOGY 1993;18:47-53.
10. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993;328:1797-1801.
11. Cottone M, Turri M, Caltagirone M, Parisi P, Orlando A, Fiorentino G, et al. Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-years prospective study by ultrasound and alphafetoprotein. J Hepatol 1994;21:1029-1034.
12. Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Bréchet C, and the Collaborative Study Group. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 1995;122:161-168.
13. Mita E, Hayashi N, Kanazawa Y, Hagiwara H, Ueda K, Kasahara A, et al. Hepatitis C virus genotype and RNA titer in the progression of type C chronic liver disease. J Hepatol 1994;21:468-473.
14. Pozzato G, Kaneko S, Morreti M, Saveria Croce L, Franzin F, Unoura M, et al. Different genotypes of hepatitis C virus are associated with different severity of liver disease. J Med Virol 1994;43:291-296.
15. Yamada M, Kakumu S, Yoshioka K, Higashi Y, Tanaka K, Ishikawa T, et al. Hepatitis C virus genotypes are not responsible for development of serious liver disease. Dig Dis Sci 1994;39:234-239.